Pharmacokinetics and Comparative Bioavailability of Artesunate and Mefloquine Administered Separately or as a Fixed Combination Product to Healthy Volunteers and Patients with Uncomplicated Plasmodium falciparum Malaria.

Piero Olliaro^1*, Surash Ramanathan², Michel Vaillant³, Stephanie E Reuter⁴, Allan M Evans⁴, Srivicha Krudsood⁵, Sornchai Looareesuwan⁵, Jean-René Kiechel⁶, Walter RJ Taylor^1,7 and Visweswaran Navaratnam²

¹UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR), Geneva, Switzerland

²Centre for Drug Research, Universiti Sains Malaysia, Penang, Malaysia

³Clinical Epidemiology and Public Health Unit, Centre for Health Studies, CRP-Santé, Luxembourg

⁴School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, Australia

⁵Hospital for Tropical Disease, Bangkok, Thailand

⁶Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

⁷Division of International and Humanitarian Medicine, Geneva, Swaziland

^*Corresponding Author: